Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 13/20 | 0.55 |
| ▸ | LPL | P06858 | 12/20 | 0.55 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 3/20 | 0.46 |
| ▸ | CA2 | P00918 | 3/20 | 0.46 |
| ▸ | CA9 | Q16790 | 3/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA3 | P07451 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | CA6 | P23280 | 1/20 | 0.46 |
| ▸ | CA5A | P35218 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.46 |
| ▸ | F11 | P03951 | 2/20 | 0.45 |
| ▸ | P4HB | P07237 | 1/20 | 0.40 |
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.39 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.39 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17129595 | 0.85 | CA1 (0.47) | LIPGLPLESR2CA1CA2 | |
| SCHEMBL28371250 | 0.85 | LIPG (0.57) | LIPGLPLESR2CA1CA2 | |
| SCHEMBL228212 | 0.84 | LPL (0.71) | LIPGLPLESR2CA1CA2 | |
| SCHEMBL14694493 | 0.84 | LPL (0.52) | LIPGLPLESR2CA1CA2 | |
| SCHEMBL14694622 | 0.84 | LIPG (0.52) | LIPGLPLESR2CA1CA2 | |
| SCHEMBL24775237 | 0.84 | LIPG (0.52) | LIPGLPLESR2CA1CA2 | |
| SCHEMBL24774874 | 0.84 | LIPG (0.52) | LIPGLPLESR2CA1CA2 | |
| SCHEMBL19110515 | 0.84 | LPL (0.52) | LIPGLPLESR2CA1CA2 | |
| SCHEMBL20108614 | 0.84 | LPL (0.52) | LIPGLPLESR2CA1CA2 | |
| SCHEMBL2590038 | 0.84 | LPL (0.52) | LIPGLPLESR2CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116874370-B | Carnosic acid derivative and preparation method and application thereof | 山东省药学科学院 | 2025-03-18 | — | — | CN | disclosed |
| EP-4448513-A1 | 3, 4-DIHYDROISOQUINOLIN-1 (2H) -ONES DERIVATIVES AS STING ANTAGONISTS AND THE USE THEREOF | BeiGene Switzerland GmbH (CH) | 2024-10-23 | — | — | EP | disclosed |
| US-11834460-B2 | Imide-based modulators of proteolysis and associated methods of use | YALE UNIVERSITY (US) | 2023-12-05 | — | — | US | disclosed |
| CN-116874370-A | Carnosic acid derivative and preparation method and application thereof | 山东省药学科学院 | 2023-10-13 | — | — | CN | disclosed |
| US-20230263893-A1 | COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF BROMODOMAIN-CONTAINING PROTEINS | ARVINAS OPERATIONS, INC. | 2023-08-24 | — | — | US | disclosed |
| WO-2023109912-A1 | 3, 4-DIHYDROISOQUINOLIN-1 (2H) -ONES DERIVATIVES AS STING ANTAGONISTS AND THE USE THEREOF | BEIGENE, LTD. (KY) | 2023-06-22 | — | — | WO | disclosed |
| CN-111943967-B | Method for synthesizing alkenyl borate compound | 温州大学 | 2023-03-28 | — | — | CN | disclosed |
| CN-108341774-B | Substituted quinolinone inhibitors | 首药控股(北京)股份有限公司 | 2022-07-19 | — | — | CN | disclosed |
| CN-110938097-A | Green phosphorescent compound and organic electroluminescent device using the same | 浙江华显光电科技有限公司 | 2020-03-31 | — | — | CN | disclosed |
| US-10227267-B2 | Bonding agents for nitrogen-containing oxidizers | RAYTHEON COMPANY (US) | 2019-03-12 | — | — | US | disclosed |
| US-7947828-B2 | Methods and intermediates for the synthesis of dipyrrin-substituted porphyrinic macrocycles | NORTH CAROLINA STATE UNIVERSITY (US) | 2011-05-24 | — | — | US | disclosed |
| US-7947828-B2 | Methods and intermediates for the synthesis of dipyrrin-substituted porphyrinic macrocycles | NORTH CAROLINA STATE UNIVERSITY (US) | 2011-05-24 | — | — | US | disclosed |
| US-20100200066-A1 | METHODS AND INTERMEDIATES FOR THE SYNTHESIS OF DIPYRRIN-SUBSTITUTED PORPHYRINIC MACROCYCLES | UNITED STATE DEPARTMENT OF ENERGY | 2010-08-12 | — | — | US | disclosed |
| US-20100200066-A1 | METHODS AND INTERMEDIATES FOR THE SYNTHESIS OF DIPYRRIN-SUBSTITUTED PORPHYRINIC MACROCYCLES | UNITED STATE DEPARTMENT OF ENERGY | 2010-08-12 | — | — | US | disclosed |
| US-7723513-B2 | for production of molecular memory devices, solar cells and light harvesting arrays | NORTH CAROLINA STATE UNIVERSITY (US) | 2010-05-25 | — | — | US | disclosed |
| US-7723513-B2 | for production of molecular memory devices, solar cells and light harvesting arrays | NORTH CAROLINA STATE UNIVERSITY (US) | 2010-05-25 | — | — | US | disclosed |
| US-7332599-B2 | Reacting a dipyrromethane with an oxidant and a metal salt to produce the bis(dipyrrinato)metal complex; for making molecular memory devices, solar cells and light harvesting arrays | NORTH CAROLINA STATE UNIVERSITY (US) | 2008-02-19 | — | — | US | disclosed |
| US-7332599-B2 | Reacting a dipyrromethane with an oxidant and a metal salt to produce the bis(dipyrrinato)metal complex; for making molecular memory devices, solar cells and light harvesting arrays | NORTH CAROLINA STATE UNIVERSITY (US) | 2008-02-19 | — | — | US | disclosed |
| US-20070191600-A1 | for production of molecular memory devices, solar cells and light harvesting arrays | NORTH CAROLINA STATE UNIVERSITY (US) | 2007-08-16 | — | — | US | disclosed |
| US-20070191600-A1 | for production of molecular memory devices, solar cells and light harvesting arrays | NORTH CAROLINA STATE UNIVERSITY (US) | 2007-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100200066-A1 | METHODS AND INTERMEDIATES FOR THE SYNTHESIS OF DIPYRRIN-SUBSTITUTED PORPHYRINIC MACROCYCLES | HCCS, PPOX, DHPS | LIPG 4782/4885LPL 4709/4885ESR2 3967/4885 |
| US-20230263893-A1 | COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF BROMODOMAIN-CONTAINING PROTEINS | BRPF3, STUB1, BRDT | LIPG 1894/4885LPL 3344/4885ESR2 1490/4885 |
| US-11834460-B2 | Imide-based modulators of proteolysis and associated methods of use | CRBN, MDM2, UBE2N | LIPG 3344/4885LPL 4257/4885ESR2 1959/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.